Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia ; day:16 ; month:9 ; year:2020 ; pages:1-16
Clinical pharmacokinetics ; (16.9.2020), 1-16
- Creator
-
Preijers, Tim
Schütte, Lisette M.
Kruip, Marieke J. H. A.
Cnossen, Marjon H.
Leebeek, Frank W. G.
Hest, Reinier M. van
Mathôt, Ron A. A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-020-00936-5
- URN
-
urn:nbn:de:101:1-2020110518303937645521
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Preijers, Tim
- Schütte, Lisette M.
- Kruip, Marieke J. H. A.
- Cnossen, Marjon H.
- Leebeek, Frank W. G.
- Hest, Reinier M. van
- Mathôt, Ron A. A.
- SpringerLink (Online service)
Other Objects (12)
Circumcision in hemophilia using low quantity of factor concentrates: experience from Dakar, Senegal
Recombinant Factor VIII Concentrates
Pharmacokinetics of Human Factor IX in a dog with Severe Hemophilia B.
Clinical Use of Factor IX Concentrates
Particulate Material in Factor VIII Concentrates
Heterogeneity of Factor IX in Therapeutic Concentrates
Human Factor VIII Concentrates in Hemophiliac Dogs
Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
Degradation of Factor VIII-Related Protein in Factor VIII Concentrates
Factor VIII Concentrates - Forces of Supply and Demand
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Circumcision in hemophilia using low quantity of factor concentrates: experience from Dakar, Senegal
Recombinant Factor VIII Concentrates
Pharmacokinetics of Human Factor IX in a dog with Severe Hemophilia B.
Clinical Use of Factor IX Concentrates
Particulate Material in Factor VIII Concentrates
Heterogeneity of Factor IX in Therapeutic Concentrates
Human Factor VIII Concentrates in Hemophiliac Dogs
Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
Degradation of Factor VIII-Related Protein in Factor VIII Concentrates
Factor VIII Concentrates - Forces of Supply and Demand
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Circumcision in hemophilia using low quantity of factor concentrates: experience from Dakar, Senegal
Recombinant Factor VIII Concentrates
Pharmacokinetics of Human Factor IX in a dog with Severe Hemophilia B.
Clinical Use of Factor IX Concentrates
Particulate Material in Factor VIII Concentrates
Heterogeneity of Factor IX in Therapeutic Concentrates
Human Factor VIII Concentrates in Hemophiliac Dogs
Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
Degradation of Factor VIII-Related Protein in Factor VIII Concentrates
Factor VIII Concentrates - Forces of Supply and Demand